Alzheimer's Association

• Maria C Carrillo

  Chief science officer

Sources: reporter.nih.gov

• The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease

  Collaborator, Recruiting, 60 people, 25 Sept 2026

• Fostering Positive Care Interactions in Assisted Living

  Collaborator, Recruiting, 100 people, 30 Jan 2026

• The Effect of Combination of Mediterranean Diet and Oleocanthal in Patients With Mild Cognitive Impairment

  Collaborator, Recruiting, 200 people, 26 Nov 2024

• NCT06582706

  Collaborator, Phase 1/2, Recruiting, 30 people, 3 Sept 2024

• NCT06384573

  Collaborator, Phase 3, Active, not recruiting, 40 people, 25 Apr 2024

• NCT06072963

  Collaborator, Phase 2, Recruiting, 80 people, 10 Oct 2023

• NCT05269394

  Collaborator, Phase 2/3, Active, not recruiting, 197 people, 8 Mar 2022

• NCT04784416

  Collaborator, Phase 2, Active, not recruiting, 196 people, 5 Mar 2021

• NCT04629495

  Collaborator, Phase 2, Active, not recruiting, 40 people, 16 Nov 2020

• NCT04623242

  Collaborator, Phase 2/3, Completed, 194 people, 10 Nov 2020

• NCT04522739

  Collaborator, Phase 4, Completed, 25 people, 21 Aug 2020

• NCT04289142

  Collaborator, Phase 4, Recruiting, 2,400 people, 28 Feb 2020

• NCT01760005

  Collaborator, Phase 2/3, Active, not recruiting, 490 people, 3 Jan 2013

• NCT01595646

  Collaborator, Phase 2, Completed, 37 people, 10 May 2012

• NCT00792662

  Collaborator, Phase 4, Withdrawn, 0 people, 18 Nov 2008

• NCT00678431

  Collaborator, Phase 3, Completed, 27 people, 15 May 2008

• NCT00580931

  Collaborator, Phase 1/2, Completed, 50 people, 27 Dec 2007

• NCT00006399

  Collaborator, Phase 2, Completed, 45 people, 21 Aug 2000

Sources: clinicaltrials.gov

• National Institute on Aging

  R13, Early-onset Alzheimer’s and other dementia: From natural history to clinical trials, R13AG072859, US$44.2k, 2021–2026, 31 Mar 2023

Sources: reporter.nih.gov

• Muna Therapeutics

• Andrea L. Benedet

  AARG, Diversity in Alzheimer’s Disease Biomarkers: A Population-Based Approach, 26AARGA-1565283, 2026, 1 Jan 2026

• University of Gothenburg

  AARG, Diversity in Alzheimer’s Disease Biomarkers: A Population-Based Approach, 26AARGA-1565283, 2026, 1 Jan 2026

• Daniel Panyard

  BFDN, Molecular mediators of cardiometabolic risk factors and Alzheimer’s disease, 26BFDN-1610132C, 2026, 1 Jan 2026

• Stanford University

  BFDN, Molecular mediators of cardiometabolic risk factors and Alzheimer’s disease, 26BFDN-1610132C, 2026, 1 Jan 2026

• Emma Coomans

  AARF, Identifying time windows and pathways for delaying AD age-at-onset, 26AARFA-1563563, 2026, 1 Jan 2026

• Amsterdam UMC

  AARF, Identifying time windows and pathways for delaying AD age-at-onset, 26AARFA-1563563, 2026, 1 Jan 2026

• Chenxi Yuan

  BFDN, Verified Fair Models for Predicting Progression in Alzheimer's Disease, 26BFDN-1609491C, 2026, 1 Jan 2026

• New Jersey Institute of Technology

  BFDN, Verified Fair Models for Predicting Progression in Alzheimer's Disease, 26BFDN-1609491C, 2026, 1 Jan 2026

• Luis Soto-Rojas

  PTC, Creatine-Augmented Exercise for Neuroprotection in Early AD patients, PTC-26-1566476, 2026, 1 Jan 2026

• Universidad Nacional Autonoma de Mexico

  PTC, Creatine-Augmented Exercise for Neuroprotection in Early AD patients, PTC-26-1566476, 2026, 1 Jan 2026

• Juan Palavicini

  AARG, Gene-Environment Synergy: Circadian and Metabolic Triggers in MAPT-GR Mice, 26AARGA-1574562, 2026, 1 Jan 2026

• The University of Texas Health Science Center at San Antonio

  AARG, Gene-Environment Synergy: Circadian and Metabolic Triggers in MAPT-GR Mice, 26AARGA-1574562, 2026, 1 Jan 2026

• Elizabeth Rhea

  BFDN, Insulin as a molecular mediator of the cognitive protection of exercise, 26BFDN-1676454E, 2026, 1 Jan 2026

• Seattle Institute for Biomedical and Clinical Research

  BFDN, Insulin as a molecular mediator of the cognitive protection of exercise, 26BFDN-1676454E, 2026, 1 Jan 2026

• Holly Hunsberger

  BFDN, Understanding hippocampal circuits during perimenopause in AD mice, 26BFDN-1572151C, 2026, 1 Jan 2026

• Rosalind Franklin University of Medicine and Science

  BFDN, Understanding hippocampal circuits during perimenopause in AD mice, 26BFDN-1572151C, 2026, 1 Jan 2026

• Addam Reynolds

  AARF, Sexual and Gender Minorities and ADRD, 26AARFA-1573453, 2026, 1 Jan 2026

• University of Southern California

  AARF, Sexual and Gender Minorities and ADRD, 26AARFA-1573453, 2026, 1 Jan 2026

• Brandon Yates

  BFDN, Neurovascular Contributions to Post-ICU Cognitive and Mental Decline, 26BFDN-1593407D, 2026, 1 Jan 2026

Sources: munatherapeutics.com, openalex.org

• Blood Biomarkers of Alzheimer's Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial

  6 Oct 2026

• Different functional connectivity gradients reflect aging and Alzheimer's disease

  ZEN24-1069572, SG-23-1061717, 1 Oct 2026

• Speech clocks decode dementia phenotypes, social exposome, and biological aging

  SG-20-725707, ALZ-RWD-26-1466627, AARGD-24-1310017, ANID/FOVI240065, 30 Sept 2026

• Lewy Body Disease Across Aging: Clinical and Neuropathological Correlates in a Population Brain Bank

  AARG‐20‐678884, 24CBIDR‐1185483, AARGD‐22‐972378, 27 Sept 2026

• Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs

  22 Sept 2026

• A caution in interpreting reliable cognitive decline in older adults at risk for Alzheimer's disease

  17 Sept 2026

• Serum metabolite signature of the mediterranean diet adherence and cognitive function: Evidence from two cohorts

  AARG-NTF-23-1027318, 16 Sept 2026

• Subjective word-finding complaints in older adults: Development and preliminary psychometric evaluation of a novel self-reported questionnaire

  AARG-22-927100, 14 Sept 2026

• Telomerase reverse transcriptase as a core regulator of brain health

  11 Sept 2026

• Individual Differences in Cognitive Aging Rodent Datasets (ID-CARD): A collaborative platform for behavioral analysis across the lifespan

  10 Sept 2026

• Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases

  AARGD‐24‐1294531, 8 Sept 2026

• Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains

  HRS‐18‐586069C, 8 Sept 2026

• Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies

  8 Sept 2026

• Mild behavioral impairment and risk of incident dementia: A systematic review and meta-analysis

  7 Sept 2026

• Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study

  3 Sept 2026

• Blood-based biomarkers of Alzheimer's disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms

  GBHI ALZ UK-21-724204, 2 Sept 2026

• Older adult APOE4 mice exhibit modest immunometabolic adaptation following microglial APOE2 replacement

  ABA-22-972169, 2 Sept 2026

• Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease

  1 Sept 2026

• Adverse policing as a social exposome pathway: Implications for depression, cognition, and dementia risk

  AARGD‐22‐973213, 1 Sept 2026

• A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias

  K23AG093166, SG-20-725707, AARG-21-848397, 1 Sept 2026

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

• Epigenetic clocks of biological aging and cognitively healthy longevity: the Women's Health Initiative Memory Study

  Grants or research support, 6 Oct 2026

• Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality

  Board or leadership role, 1 Oct 2026

• Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change

  Fees or honoraria, Grants or research support, 1 Oct 2026

• Blood proteomics of menopause map to brain aging and dementia risk

  Board or leadership role, 22 Sept 2026

• A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

  Grants or research support, 21 Sept 2026

• Cognitive and Behavioral Functioning in Female Former Soccer Players: Results from the Head Impact and Trauma Surveillance Study (HITSS)

  Fees or honoraria, Grants or research support, 15 Sept 2026

• Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial

  Grants or research support, 14 Sept 2026

• Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies

  Grants or research support, 9 Sept 2026

• Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studies

  Grants or research support, 8 Sept 2026

• Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease

  Fees or honoraria, Grants or research support, 1 Sept 2026

• More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts

  Grants or research support, 1 Sept 2026

• Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial

  Grants or research support, 1 Sept 2026

• A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias

  Fees or honoraria, Grants or research support, 1 Sept 2026

• Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome

  Consulting or advice, Fees or honoraria, Grants or research support, 1 Sept 2026

• Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study

  Grants or research support, 28 Aug 2026

• A multiancestry polygenic risk score for Alzheimer's disease is associated with cognitive decline and neuropathological hallmarks in diverse populations

  Fees or honoraria, Grants or research support, 27 Aug 2026

• Chronic stress, social support, and domain-specific cognitive decline in HABS-HD

  Grants or research support, 1 Aug 2026

• Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell-specific extracellular vesicles

  Grants or research support, 1 Aug 2026

• Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia

  Grants or research support, 25 Sept 2025

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org

• The Alzheimer's Association 2024 diagnostic criteria: Generalizability of supporting autopsy evidence

  Journal of Alzheimer's disease : JAD, 9 Oct 2026

• What Increases the Likelihood of Dementia Among Asian Americans? Analysis of Nativity and Life Course Factors

  Journal of racial and ethnic health disparities, 28 Sept 2026

• A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

  JAMA neurology, 21 Sept 2026

• Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease

  Alzheimer's & dementia : the journal of the Alzheimer's Association, 15 Sept 2026

• Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)

  Alzheimer's & dementia : the journal of the Alzheimer's Association, 14 Sept 2026

• Insulin resistance and brain health in midlife: a potential dementia prevention target

  EBioMedicine, 21 Aug 2026

• Assessing the relationships between frailty, sarcopenia and Alzheimer's disease biomarkers: A scoping review

  Ageing research reviews, 8 Jul 2026

• Hippocampal asymmetry captures non-amyloid-related risk of memory decline and clinical progression

  The journal of prevention of Alzheimer's disease, 7 Jul 2026

• Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease

  Alzheimer's & dementia : the journal of the Alzheimer's Association, 3 Feb 2026

• Alzheimer's Disease Begins Years Before Symptoms: Alzheimer's Association Workgroup

  AAIC 2025 abstract, 10 Jan 2026

• NCRAD: A Critical Resource for the Alzheimer's Disease and Related Dementias Research Community

  AAIC 2025 abstract, 9 Jan 2026

• Plasma proteomic signatures of incident mild behavioral impairment – a longitudinal Singaporean memory clinic study

  AAIC 2025 abstract, 9 Jan 2026

• Proteomics at our fingertips: Coupling remote collection devices with NULISA multiplex panels

  AAIC 2025 abstract, 26 Dec 2025

• Serum β‐Synuclein as a Potential Early Biomarker for Alzheimer's Disease

  AAIC 2025 abstract, 25 Dec 2025

• Disentangling risk of progression and clinical trajectories in preclinical AD: views from the International Working Group

  AAIC 2025 abstract, 25 Dec 2025

• Lower amyloid and small vessel disease in unimpaired older adults with Down syndrome

  AAIC 2025 abstract, 24 Dec 2025

• Spatial molecular characterization of early Alzheimer's disease neuropathology in aged Vervet monkeys

  AAIC 2025 abstract, 24 Dec 2025

• Modulation of Amyloid‐beta Metabolism by TIMP2 and MMP2 Through Extracellular Matrix Interactions in Mouse Models of Alzheimer's Pathology

  AAIC 2025 abstract, 24 Dec 2025

• Clinical Practice Guideline on Cognitive Assessments for the Early Detection of Cognitive Impairment in Primary Care: A report from the Alzheimer's Association

  AAIC 2025 abstract, 23 Dec 2025

• U.S. POINTER: Design of the Multidomain Lifestyle Interventions

  AAIC 2025 abstract, 23 Dec 2025